Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligandsNEUROBIOLOGY OF DISEASEIF5.62017-01-0142PREAI
Controlled Striatal DOPA Production From a Gene Delivery System in a Rodent Model of Parkinson's DiseaseMOLECULAR THERAPYIF122015-05-0120OAAI
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's diseaseSCIENTIFIC REPORTSIF3.92013-07-0823OAAI
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brainNEUROBIOLOGY OF DISEASEIF5.62012-11-014PREAI
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's DiseaseMOLECULAR THERAPYIF122012-07-0128OAAI
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson's diseaseBRAINIF11.72010-02-0247OAAI